Security key
63909J108
Nautilus Biotechnology, Inc. - Common Stock, par value $0.0001 per share (NAUT)
CUSIP: 63909J108
Q3 2022 13F Holders as of 30 Sep 2022
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 56,460,432
- Total 13F value
- $119,696,429
- Share change
- -1,061,288
- SEC-reported price per share
- $2.12
- Number of holders
- 77
- Value change
- -$2,490,160
- Number of buys
- 24
- Number of sells
- 30
- Shares outstanding
- 127,821,122
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2022
Institutions
77
Top holders
10
NAUT full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2025
Nautilus Biotechnology, Inc. SEC filings
Nautilus Biotechnology, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 63909J108
Recent filing periods:
Ownership snapshot
Top reported holders of NAUT - Nautilus Biotechnology, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
AH Equity Partners Bio II...
Disclosed value leader
AH Equity Partners Bio II...
Comparable rows
15/15
Latest evidence
30 Jun 2022
13F
Lead comparable stake: 13%
Showing 1-6 of 15 holder rows.
Quick read
AH Equity Partners Bio II, L.L.C. leads the comparable SEC ownership view at 13%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens AH Equity Partners Bio II, L.L.C.'s linked filing trail.
Comparable ownership
Top 5
AH Equity Partners Bio II, L.L.C.
13%
PERCEPTIVE ADVISORS LLC
7.1%
Madrona Venture Group, LLC
4.7%
BlackRock Finance, Inc.
2.5%
Comprehensive Financial Managemen...
1.7%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| AH Equity Partners Bio II, L.L.C. |
13F
Company
|
13%
|
$43,842,000
16,298,006 shares
|
— | 30 Jun 2022 |
| PERCEPTIVE ADVISORS LLC |
13F
Company
|
7.1%
|
$24,508,000
9,111,151 shares
|
— | 30 Jun 2022 |
| Madrona Venture Group, LLC |
13F
Company
|
4.7%
|
$16,196,000
6,020,770 shares
|
— | 30 Jun 2022 |
| BlackRock Finance, Inc. |
13F
Company
|
2.5%
|
$8,758,000
3,256,032 shares
|
— | 30 Jun 2022 |
| Comprehensive Financial Management LLC |
13F
Company
|
1.7%
|
$5,984,000
2,224,619 shares
|
— | 30 Jun 2022 |
| VANGUARD GROUP INC |
13F
Company
|
1.7%
|
$5,865,000
2,180,320 shares
|
— | 30 Jun 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
77
Shares
56,460,432
Rows available
77
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2022 vs Q2 2022 Across Filers
Q2 2022 holders
80
Q3 2022 holders
77
Holder diff
-3
| Investor | Q2 2022 Shares | Q3 2022 Shares | Share Diff | Share Chg % | Q2 2022 value | Q3 2022 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend